Global Pharmaceutical Outsourcing Market Report 2015 - New Trends on the Horizon
DUBLIN, Apr. 10, 2015 /PRNewswire/ --Research and Markets
(http://www.researchandmarkets.com/research/p7pd37/the_new_trends_of) has announced the addition of the "The New Trends of Global Pharmaceutical Outsourcing - Second Edition" report to their offering.
The escalating operation cost for every drug company and the vigorous control of the healthcare cost by the government in almost all countries, coupled with the low efficiency in their operation for a number of years, have forced all drug companies to seriously address these issues. Streamlining their internal operation and more diligently seeking external resources have become their core strategies.
Besides the operational factors, the fast emerging of new technologies in drug R&D has also forced drug companies to rapidly adapt to the new R&D environment. Today, drug companies are in a desperate need to develop better drugs with high success rates and low cost. To achieve these goals, they increasingly resort to the combination of internal effort and external resources.
The report, The New Trends of Global Pharmaceutical Outsourcing - Second Edition, provides unique insights into the new outsourcing demands and strategies of global drug companies large and small in both R&D and manufacturing and in both small molecules and biologics. The report helps professionals in the life science-related industries gain a better view about what is really going on currently in the global pharmaceutical outsourcing industry. It also includes the in-depth analyses on the new outsourcing models currently practiced by drug companies.
The report provides the unique insights into the latest trends of the global pharmaceutical outsourcing in both R&D and manufacturing, in both small molecules and biologics, and in both major pharma companies and R&D-focused biotech companies. It is a must-read book to all pharmaceutical and biotechnology companies that seek outsourcing opportunities in both R&D and manufacturing, professional outsourcing service providers that need to conceive their future business development directions, and venture capital investors that are looking for investment opportunities in the global pharmaceutical industry.
Key Topics Covered:
Executive Summary
Global drug companies' new outsourcing demands
New trends in drug discovery outsourcing
New trends in drug development outsourcing
New trends in pharmaceutical manufacturing outsourcing
Chapter One - Global Drug Companies' New Outsourcing Demands
1.1 Introduction
1.2 Major pharma companies forced to increase outsourcing
1.3 Disease biology-focused drug discovery approaches forcing drug companies to seek external partners
1.4 Strong outsourcing demands from global drug R&D-focused small biotech companies
Chapter Two - New Trends in Drug Discovery Outsourcing
2.1 Introduction
2.2 New trends in compound library development
2.3 New trends in target discovery outsourcing
2.4 New drug discovery partnership models with academics
2.5 Drug companies' new outsourcing strategies and models on small molecule drug discovery
2.6 Major pharma companies' new strategies on biologic drug discovery outsourcing
2.7 New trends in IND-enabling drug discovery outsourcing
Chapter Three - New Trends in Drug Development Outsourcing
3.1 Introduction
3.2 New developments in clinical trials
3.3 New technologies incorporated into clinical trials and drug companies' new outsourcing strategies in these areas
3.4 Drug companies' new clinical trial outsourcing strategies
3.5 Clinical trial CRO consolidation becoming a trend
Chapter Four - New Trends in Pharmaceutical Manufacturing Outsourcing
4.1 Introduction
4.2 Major pharma companies' new outsourcing strategies on small molecule drug manufacturing
4.3 R&D-focused small biotech companies' current outsourcing demands and strategies for small molecule manufacturing services
4.4 Small molecule manufacturing service-focused CMOs experiencing significant consolidations
4.5 Latest trends of small molecule manufacturing outsourcing in emerging countries
4.6 New trends in biomanufacturing outsourcing
4.7 Major pharma companies' new outsourcing demands and strategies on biologic product manufacturing
4.8 New biomanufacturing outsourcing demands and strategies of R&D-focused small biotech companies
For more information visit http://www.researchandmarkets.com/research/p7pd37/the_new_trends_of
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets
Share this article